Yes. Potentially life-saving drugs in RCTs are usually compared to "standard of care," i.e. already-approved treatments, not to placebos.
replySo if both the standard of care as well as the drug being trials have the same side effects, would they be included in the package insert/drug literature? Because the incidence rate of it would be same for both the groups?
reply